SG Americas Securities
GNCA

SG Americas Securities’s Genocea Biosciences, Inc. GNCA Stock Holding History

SG Americas Securities’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,967
Closed -$25K – 3660
2018
Q1 		$25K Buy
2,967
+1,110
+60% +$9.22K ﹤0.01% 3143
2017
Q4 		$17K Sell
1,857
-253
-12% -$2.54K ﹤0.01% 3063
2017
Q3 		$25K Buy
+2,110
New +$80.1K ﹤0.01% 3390

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SG Americas Securities's GNCA Position: Q2 2018 in Review

SG Americas Securities sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2018, closing a stake of 2,967 shares — an estimated $25K sold.

SG Americas Securities first reported a position in GNCA in Q3 2017 and held it in 3 quarters. The position peaked at $25K in Q1 2018. 54 funds tracked by Wall St. Rank hold GNCA as of Q2 2018.

  • SG Americas Securities reported no remaining Genocea Biosciences, Inc. position as of Q2 2018 after selling out during the quarter.
  • SG Americas Securities sold 2,967 Genocea Biosciences, Inc. shares in Q2 2018, an estimated $25K.
  • SG Americas Securities first reported a position in Genocea Biosciences, Inc. in Q3 2017 and held it in 3 quarters.
  • SG Americas Securities's Genocea Biosciences, Inc. position peaked at $25K in Q1 2018.
  • 54 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2018.

Based on SG Americas Securities's 13F filing for Q2 2018, filed 7 Aug 2018.